Ipsen and Sutro Biopharma entered a global licensing deal for STRO-003, an ADC targeting ROR1, overexpressed in cancers, marking Ipsen's first ADC portfolio addition.United States, New York, Jan. 31, ...
Latin Times on MSN5mon
Researchers discover antibody that neutralizes all known COVID-19 variants, paving way for universal vaccineThe technology behind SC27's discovery, known as Ig-Seq, combines single-cell DNA sequencing with proteomics, allowing ...
Antibodies, also known as immunoglobulins (IGs), are glycoproteins produced in response to an immune reaction and exhibit high specificity for the antigens that elicit the response. An antibody ...
Chimera Biotec, founded in 2000 as a spin-off from academic research in Germany, has implemented its proprietary DNA-antibody conjugates within the highly innovative Imperacer product line ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback